EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $221,000 | -25.6% | 33,092 | -5.0% | 0.03% | -71.0% |
| Q2 2021 | $297,000 | -14.4% | 34,838 | -11.2% | 0.10% | -9.9% |
| Q1 2021 | $347,000 | -70.9% | 39,248 | -59.6% | 0.11% | -67.4% |
| Q4 2020 | $1,193,000 | +50.3% | 97,108 | -0.5% | 0.34% | +34.9% |
| Q3 2020 | $794,000 | -15.2% | 97,598 | +0.1% | 0.25% | -20.8% |
| Q2 2020 | $936,000 | +32.0% | 97,538 | -6.4% | 0.32% | +6.4% |
| Q1 2020 | $709,000 | -10.0% | 104,248 | +97.1% | 0.30% | +27.2% |
| Q4 2019 | $788,000 | +63.8% | 52,878 | +12.7% | 0.24% | +31.3% |
| Q3 2019 | $481,000 | +57.7% | 46,908 | +63.0% | 0.18% | +58.4% |
| Q2 2019 | $305,000 | +23.5% | 28,770 | +63.2% | 0.11% | -19.9% |
| Q1 2019 | $247,000 | -58.1% | 17,634 | -69.6% | 0.14% | -14.0% |
| Q4 2018 | $590,000 | -27.6% | 58,061 | -14.5% | 0.16% | -6.8% |
| Q3 2018 | $815,000 | +194.2% | 67,921 | +199.0% | 0.18% | +203.4% |
| Q2 2018 | $277,000 | – | 22,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |